v3.26.1
STOCKHOLDERS’ DEFICIT (Details Narrative)
 1 Months Ended 2 Months Ended 12 Months Ended
Jan. 16, 2026
shares
May 13, 2025
Apr. 28, 2025
shares
Feb. 17, 2025
shares
Jan. 21, 2025
shares
Jan. 03, 2025
May 22, 2024
shares
Feb. 29, 2024
Jul. 13, 2023
shares
Dec. 31, 2025
$ / shares
shares
Nov. 30, 2025
shares
Feb. 28, 2025
USD ($)
shares
Dec. 31, 2025
$ / shares
shares
Dec. 31, 2025
USD ($)
Integer
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Class of Stock [Line Items]                              
Preferred stock, shares authorized                   10,000,000     10,000,000 10,000,000 10,000,000
Preferred stock, par value | $ / shares                   $ 0.0001     $ 0.0001 $ 0.0001 $ 0.0001
Preferred stock, shares issued                   0     0 0 0
Preferred stock, shares outstanding                   0     0 0 0
Common stock, shares authorized                   490,000,000     490,000,000 490,000,000 490,000,000
Common stock, par value | $ / shares                   $ 0.0001     $ 0.0001 $ 0.0001 $ 0.0001
Common stock, shares issued                   3,533,408     3,533,408 3,533,408 690,044
Common stock, shares outstanding                   3,533,408     3,533,408 3,533,408 690,044
Reverse stock split   1-for-40                       1 for 40  
General and administrative expenses | $                           $ 17,637,432 $ 940,421
Aspire Biopharma Warrants [Member]                              
Class of Stock [Line Items]                              
Exercise price of warrants | $ / shares                             $ 0.40
Number of warrants issued                             44,000,000
Warrants outstanding         91,500,000                   91,500,000
Common stock issued upon warrant conversion         91,500,000                    
Corporate Advisory Agreement [Member]                              
Class of Stock [Line Items]                              
Shares outstanding percentage           4.75%   6.00%              
Shares issued to affiliated company                       41,563      
Business combination shares                       875,000      
General and administrative expenses | $                       $ 14,131,250      
Market price discount percentage                       15.00%      
First Subscription Agreement [Member]                              
Class of Stock [Line Items]                              
Shares issued for commitment fee                           43,750  
Blackstone Subscription Agreement [Member]                              
Class of Stock [Line Items]                              
Shares issued for commitment fee       44,875                      
Loan and Transfer Agreement [Member] | Apogee Pharma [Member]                              
Class of Stock [Line Items]                              
Reverse stock split                           1-for-40  
Number of shares issued       1,250                      
Non Redemption Agreement [Member]                              
Class of Stock [Line Items]                              
Number of shares issued             1,875                
Amended Service Agreement [Member]                              
Class of Stock [Line Items]                              
Advisory fees payable in shares                 2,000            
Settlement Agreement [Member]                              
Class of Stock [Line Items]                              
Number of shares issued     15,625                        
Second ELOC Agreement [Member] | Arena Business Solutions Global SPC II Ltd [Member]                              
Class of Stock [Line Items]                              
Number of shares issued                   75,325 75,325   75,325    
Public Warrants [Member]                              
Class of Stock [Line Items]                              
Warrants outstanding                   359,974     359,974 359,974  
Public warrant exercisable term                   30 days     30 days 30 days  
Redemption price per public warrant | $ / shares                           $ 16  
Redemption period                           30 days  
Warrant redemption condition minimum share price | $ / shares                           $ 720.00  
Threshold trading days for redemption of public warrants                           20 days  
Threshold consecutive trading days for redemption of public warrants | Integer                           30  
Private Placement Warrants [Member]                              
Class of Stock [Line Items]                              
Number of warrants issued                   244,083     244,083 244,083  
Warrants outstanding                   244,083     244,083 244,083  
Common Class A [Member]                              
Class of Stock [Line Items]                              
Common stock, par value | $ / shares                   $ 0.0001     $ 0.0001 $ 0.0001  
Common Class A [Member] | Public Warrants [Member]                              
Class of Stock [Line Items]                              
Exercise price of warrants | $ / shares                   460     460 460  
Common Class A [Member] | Private Placement Warrants [Member]                              
Class of Stock [Line Items]                              
Exercise price of warrants | $ / shares                   $ 460     $ 460 $ 460  
Subsequent Event [Member]                              
Class of Stock [Line Items]                              
Reverse stock split 1-for-40                            
Subsequent Event [Member] | Aspire Biopharma Warrants [Member]                              
Class of Stock [Line Items]                              
Common stock issued upon warrant conversion 143,393